论文信息 - S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE 1B RESULTS - 字舞流文

S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE 1B RESULTS

S. Kambhampati | N. Daver | G. Ramsingh | A. Asch | D. Sallman | G. Mannis | J. Zeidner | W. Chai-Ho | T. Bradley | M. A. Al Malki | D. Jeyakumar | I. Lal | G. Xing | E. Wang | C. Renard | P. Vyas | M. Chao | R. Larson | T. Tanaka